Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an ...
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...
A fresh clinical update has been released. The post Why investors are watching this ASX healthcare stock appeared first on ...
It’s a problem with not nearly enough attention. Prostate cancer hits men hard all over the world—it’s one of the biggest ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
"Seven in 10 people now survive their cancer 5 years or more, up from only half in the mid-70s," Siegel said in a press ...
Radiotherapy professionals from 10 Asian countries have completed an IAEA training course on ultra-hypofractionated radiotherapy — a way of treating cancer with ionizing radiation that reduces ...
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback